ArticleCirculation reports2026
Optimal Endpoint for Balloon Pulmonary Angioplasty Based on Distal Pulmonary Artery Pressure Waveforms.
Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Balloon pulmonary angioplasty (BPA) is an established therapy for chronic thromboembolic pulmonary hypertension (CTEPH), but its optimal lesion-specific endpoint remains unclear. This study aimed to clarify the optimal endpoint for pressure-guided BPA (PG-BPA) based on the distal pulmonary artery pressure waveform (Pd-WF). Methods and Results: We retrospectively analyzed 23 patients with CTEPH who underwent 118 PG-BPA sessions involving 424 lesions. The pressure ratio (PR; i.e., the distal-to-proximal mean pulmonary artery pressure ratio) and Pd-WF were evaluated for each lesion. Complete arterialization of the Pd-WF (Pd-CA), defined as a distal-to-proximal pulse pressure ratio >0.5, was used as the physiological endpoint. PR improved significantly from a median of 0.52 (interquartile range [IQR] 0.39-0.66) to 0.80 (IQR 0.73-0.89) after balloon dilatation (P<0.001), and Pd-CA was achieved in 63.9% of lesions. Significant decreases were seen in both mean pulmonary artery pressure (median 34 [IQR 26-50] to 19 [IQR 18-25] mmHg) and pulmonary vascular resistance (median 8.3 (IQR 5.6-13.6) to 2.7 (IQR 2.1-4.0 Wood units; both P<0.0001). The number of lesions achieving Pd-CA correlated with the percentage reduction in pulmonary vascular resistance (r=-0.52, P=0.011). Receiver operating characteristic analysis identified a PR cut-off value of 0.77 for predicting Pd-CA (area under the curve 0.86; P<0.0001). Conclusions: Pd-CA may represent an optimal physiological endpoint for PG-BPA and enable lesion-level optimization beyond angiographic assessment alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.